Schrodinger, Inc. (SDGR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Schrodinger, Inc. (SDGR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. sdgr-20260622 1540 Broadway 24th Floor New York NY FALSE 0001490978 0001490978 2026-06-22 2026-06-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________________________ FORM 8-K ________________________________________ CURRENT REPORT P
How this was made
The 30-second read
Why it matters
The key actionable items for traders are (1) the approved increase of 3,000,000 shares available under the 2022 Equity Incentive Plan and (2) governance outcomes (three Class III directors elected) plus advisory compensation approval and KPMG ratification. No earnings, guidance, or deal terms are provided.
Market read
This is a governance/equity-plan authorization update; it may influence dilution sentiment but provides no new financial targets or operational catalysts.
What to watch
The filing doesn’t quantify expected grant timing, dilution rate, or compensation changes beyond the plan amendment; without those details, price impact is likely muted.
Background
The SEC 8-K summarizes results from Schrödinger’s June 22, 2026 annual meeting, including director elections and approval of an amendment to its equity incentive plan.
Ticker impact
Schrodinger’s 8-K reports stockholders approved a 3,000,000-share increase to its 2022 equity incentive plan and elected three directors.
Likely limited near-term impact; any move would be sentiment/dilution-perception driven rather than a new earnings or cash-flow datapoint.
The filing is a routine shareholder-meeting outcome (plan share authorization, advisory comp vote, auditor ratification, director elections) without new operating metrics, guidance, or transaction terms.
Market effects
Minimal; equity-incentive share authorizations are common across software/biotech tools and typically don’t reset sector fundamentals.
None material; Nasdaq-listed governance/plan update is company-specific.
None material; no cross-border deal, regulation, or macro linkage disclosed.
Counterpoint
Traders may overreact to the share-authorizations; the vote outcome is largely procedural and may not translate into immediate dilution if grants are paced or offset by other capital actions.
Key entities
- companySchrödinger, Inc.
Nasdaq-listed company (SDGR) reporting annual meeting outcomes and equity plan amendment approval via Form 8-K.
- auditorKPMG LLP
Ratified as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.
- directorRichard A. Friesner
Elected Class III director for a three-year term expiring at the 2029 annual meeting.
- directorRosana Kapeller-Libermann
Elected Class III director for a three-year term expiring at the 2029 annual meeting.
- directorGary Sender
Elected Class III director for a three-year term expiring at the 2029 annual meeting.
